United Kingdom
# |
Name |
Operating Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 37.72 M
|
June 30, 2024 | USD 23.61 | -1.99% |
|
United Kingdom |
|
2 |
USD 21.93 M
|
Dec. 31, 2023 | USD 0.24 | -0.40% |
|
United Kingdom |
|
3 |
USD 11.88 M
|
March 31, 2024 | USD 0.80 | 0.38% |
|
United Kingdom |
|
4 |
USD 2.94 M
|
Dec. 31, 2023 | USD 32.88 | 0.83% |
|
United Kingdom |
|
5 |
USD -1.94 M
|
Dec. 31, 2023 | USD 0.20 | -3.39% |
|
United Kingdom |
|
6 |
USD -2.11 M
|
Dec. 31, 2023 | USD 0.03 | 4.40% |
|
United Kingdom |
|
7 |
USD -2.21 M
|
Dec. 31, 2023 | USD 0.04 | -11.51% |
|
United Kingdom |
|
8 |
USD -2.23 M
|
March 31, 2024 | USD 0.09 | -2.82% |
|
United Kingdom |
|
9 |
USD -6.25 M
|
March 31, 2024 | USD 1.69 | 0.00% |
|
United Kingdom |
|
10 |
USD -7.43 M
|
Dec. 31, 2023 | USD 0.70 | -3.05% |
|
United Kingdom |
|
11 |
USD -7.72 M
|
Dec. 31, 2023 | USD 1.16 | -5.69% |
|
United Kingdom |
|
12 |
USD -7.86 M
|
Dec. 31, 2023 | USD 14.61 | -1.71% |
|
United Kingdom |
|
13 |
USD -8.61 M
|
Aug. 31, 2023 | USD 0.13 | 4.36% |
|
United Kingdom |
|
14 |
USD -9.55 M
|
Dec. 31, 2023 | USD 0.05 | 1.59% |
|
United Kingdom |
|
15 |
USD -10.46 M
|
Dec. 31, 2023 | USD 0.03 | -12.38% |
|
United Kingdom |
|
16 |
USD -16.43 M
|
Dec. 31, 2023 | USD 1.09 | -19.26% |
|
United Kingdom |
|
17 |
USD -19.56 M
|
April 30, 2024 | USD 0.12 | -0.69% |
|
United Kingdom |
|
18 |
USD -21.13 M
|
Dec. 31, 2023 | USD 3.01 | 2.73% |
|
United Kingdom |
|
19 |
USD -40.68 M
|
June 30, 2024 | USD 0.07 | -16.83% |
|
United Kingdom |
|
20 |
USD -50.07 M
|
Dec. 31, 2023 | USD 5.33 | 1.52% |
|
United Kingdom |
|
21 |
USD -60.63 M
|
Dec. 31, 2023 | USD 13.39 | 4.86% |
|
United Kingdom |
|
22 |
USD -145.59 M
|
Dec. 31, 2023 | USD 2.21 | 0.46% |
|
United Kingdom |
|
23 |
USD -160.34 M
|
Dec. 31, 2023 | USD 16.92 | 0.06% |
|
United Kingdom |
|
24 |
USD -765.27 M
|
March 31, 2024 | USD 11.13 | -2.11% |
|
United Kingdom |
The Vaccines company in United Kingdom with the highest Operating Cash Flow is Genus plc (LSE: GNS.L) at USD 37.72 M.
The Vaccines company in United Kingdom with the lowest Operating Cash Flow is Roivant Sciences Ltd. (NasdaqGS: ROIV) at USD -765.27 M.
The top 10 Vaccines companies in United Kingdom by Operating Cash Flow are Genus plc, hVIVO plc, ECO Animal Health Group plc, Immunocore Holdings plc, OptiBiotix Health Plc, Genflow Biosciences plc, Roquefort Therapeutics plc, Fusion Antibodies plc, Virax Biolabs Group Limited and Arecor Therapeutics plc.
The bottom 10 Vaccines companies in United Kingdom by Operating Cash Flow are Roivant Sciences Ltd., Centessa Pharmaceuticals plc, Autolus Therapeutics plc, Bicycle Therapeutics plc, Silence Therapeutics plc, Allergy Therapeutics plc, Mereo BioPharma Group plc, Scancell Holdings plc, Akari Therapeutics, Plc and Synairgen plc.